ALDH3A1 and neoplasm: Importantly, we confirmed through mechanistic studies that ALDH3A1 is a direct transcriptional target gene of BMAL1, thus establishing a new molecular bridge between core circadian regulation and reprogramming of tumor glucose metabolism.